MindWalk Holdings (HYFT) Other financing activities (2023 - 2026)
MindWalk Holdings (HYFT) posted quarterly Other financing activities of -$1441.1 for Q1 2026, down 168.19% year-over-year from $2113.3 in Q1 2025, and down 299.91% quarter-over-quarter from $720.88 in Q4 2025.
MindWalk Holdings (HYFT) Other financing activities (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Other financing activities for 4 consecutive years, with -$1441.1 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1,441.14 |
| Jan 31, 2026 | -1,441.14 |
| Oct 31, 2025 | 720.88 |
| Oct 31, 2025 | 720.88 |
| Jul 31, 2025 | 92,428.74 |
| Jul 31, 2025 | 92,428.74 |
| Jan 31, 2025 | 2,113.28 |
| Jan 31, 2025 | 2,113.28 |
| Jul 31, 2024 | 63,537.14 |
| Jul 31, 2024 | 63,537.14 |
| Jan 31, 2024 | -1,479.44 |
| Jan 31, 2024 | -1,479.44 |
| Oct 31, 2023 | 2,212.48 |
| Oct 31, 2023 | 2,212.48 |
| Jul 31, 2023 | 62,933.12 |
| Jul 31, 2023 | 62,933.12 |
| Jan 31, 2023 | -741.39 |
| Jan 31, 2023 | -741.39 |